Clinical trial
Effects of Optimal Iodine Supplementation in Anti-thyroid Drug Therapy for Graves' Hyperthyroidism: a Prospective Randomized Controlled Trial
NCT06540469 is registered in ClinicalTrials.gov with Shandong Provincial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Optimal Iodine Supplementation in Anti-thyroid Drug Therapy for Graves' Hyperthyroidism: a Prospective Randomized Controlled Trial
- Lead sponsor
- Shandong Provincial Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2024
- Completion date
- July 31, 2028
- Enrollment
- 315 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.